Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients.
<h4>Aims</h4>This study aims to investigate the influence of MEF2A and SLC22A3-LPAL2-LPA polymorphisms on cardiovascular disease susceptibility and responsiveness to warfarin medication in Jordanian patients, during the initiation and maintenance phases of treatment.<h4>Backgrounds...
Main Authors: | Laith N Al-Eitan, Ayah Y Almasri, Adan H Alnaamneh, Ahmad Mihyar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0294226 |
Similar Items
-
Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity
by: Ibdah RK, et al.
Published: (2021-01-01) -
Lack of association between four SNPs in the <it>SLC22A3-LPAL2-LPA</it> gene cluster and coronary artery disease in a Chinese Han population: a case control study
by: Lv Xiaofei, et al.
Published: (2012-10-01) -
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
by: AL-Eitan LN, et al.
Published: (2019-01-01) -
Influence of <i>SH2B3</i>, <i>MTHFD1L</i>, <i>GGCX</i>, and <i>ITGB3</i> Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population
by: Laith N. AL-Eitan, et al.
Published: (2020-09-01) -
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01)